NCT03462615View on ClinicalTrials.gov

Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea

UnknownOBSERVATIONAL
Enrollment

930

Participants

Timeline

Start Date

April 30, 2018

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Plasmodium Falciparum MalariaPregnancy MalariaDiagnoses Disease
Interventions
DIAGNOSTIC_TEST

HS-RDT

A single finger-prick blood sample will be collected and used to test participants with the HS-RDT. The results of the results of the test will not be used for treatment purposes nor used to inform patient care.

Sponsors

Collaborators (1)

Burnet Institute
All Listed Sponsors
collaborator

Burnet Institute

OTHER

collaborator

Papua New Guinea Institute of Medical Research

OTHER_GOV

lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER

NCT03462615 - Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea | Biotech Hunter | Biotech Hunter